Literature DB >> 27997711

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.

Veronica Redaelli1, Giacomina Rossi1, Emanuela Maderna1, Gabor G Kovacs2, Elena Piccoli1, Paola Caroppo1, Francesca Cacciatore1, Sonia Spinello1, Marina Grisoli1, Giuliano Sozzi3, Andrea Salmaggi3, Fabrizio Tagliavini1, Giorgio Giaccone1.   

Abstract

Null mutations in progranulin gene (GRN) reduce the progranulin production resulting in haploinsufficiency and are tightly associated with tau-negative frontotemporal lobar degeneration with TAR DNA-binding protein 43-positive inclusions (FTLD-TDP). Missense mutations of GRN were also identified, but their effects are not completely clear, in particular unanswered is the question of what neuropathology they elicit, also considering that their occurrence has been reported in patients with typical clinical features of Alzheimer disease. They describe two fraternal twins carrying the missense GRN Cys139Arg mutation affected by late-onset dementia and we report the neuropathological study of one of them. Both patients were examined by neuroimaging, neuropsychological assessment and genetic analysis of GRN and other genes associated with dementia. The brain of one was obtained at autopsy and examined neuropathologically. One sister presented clinical and MRI features leading to the diagnosis of Alzheimer disease. The other underwent autopsy and the brain showed neuropathological hallmarks of Alzheimer disease with abundant Aβ-amyloid deposition and Braak stage V of neurofibrillary pathology, in the absence of the hallmark lesions of FTLD-TDP. Their findings may contribute to better clarify the role of progranulin in neurodegenerative diseases indicating that some GRN mutations, in particular missense ones, may act as strong risk factor for Alzheimer disease rather than induce FTLD-TDP.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  Alzheimer disease; Frontotemporal lobar degeneration; Progranulin; genetics; neuropathology; point mutation

Mesh:

Substances:

Year:  2017        PMID: 27997711     DOI: 10.1111/bpa.12480

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  5 in total

1.  Progranulin mutations in clinical and neuropathological Alzheimer's disease.

Authors:  Badri N Vardarajan; Dolly Reyes-Dumeyer; Angel L Piriz; Rafael A Lantigua; Martin Medrano; Diones Rivera; Ivonne Z Jiménez-Velázquez; Eden Martin; Margaret A Pericak-Vance; William Bush; Lindsay Farrer; Jonathan L Haines; Li-San Wang; Yuk Yee Leung; Gerard Schellenberg; Walter Kukull; Philip De Jager; David A Bennett; Julie A Schneider; Richard Mayeux
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

2.  Mapping the genetic landscape of early-onset Alzheimer's disease in a cohort of 36 families.

Authors:  Merel O Mol; Sven J van der Lee; Marc Hulsman; Yolande A L Pijnenburg; Phillip Scheltens; Harro Seelaar; John C van Swieten; Laura Donker Kaat; Henne Holstege; Jeroen G J van Rooij
Journal:  Alzheimers Res Ther       Date:  2022-06-01       Impact factor: 8.823

3.  Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by GRN Mutations.

Authors:  Christopher J Holler; Georgia Taylor; Qiudong Deng; Thomas Kukar
Journal:  eNeuro       Date:  2017-08-18

Review 4.  An update on genetic frontotemporal dementia.

Authors:  Caroline V Greaves; Jonathan D Rohrer
Journal:  J Neurol       Date:  2019-05-22       Impact factor: 4.849

Review 5.  Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.

Authors:  Benedetta Nacmias; Silvia Bagnoli; Irene Piaceri; Sandro Sorbi
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.